Anebulo Pharmaceuticals, Inc.

Anebulo Pharmaceuticals, Inc.

ANEB · Nasdaq

Anebulo Pharmaceuticals, Inc. (ANEB) is a Biotechnology company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for Anebulo Pharmaceuticals, Inc. in 2026.

Earnings calendar

Next earnings date

—

Not scheduled

EPS estimate

—

Revenue estimate

—

Past earnings

07 May 2026
EPS actual
—
estimate -0.14
Revenue actual
—
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
12 Feb 2026
EPS actual
-0.05 (+61.5%)
estimate -0.13
Revenue actual
—
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
Beat Miss usd

Dividend calendar

No dividend history available.

EPS (Earnings Per Share)

Revenue

Company profile

Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The company was incorporated in 2020 and is based in Lakeway, Texas.

Sector
Healthcare
Industry
Biotechnology
Country
United States
Exchange
Nasdaq
CEO
Richard Anthony Cunningham
Employees
2
IPO date
07 May 2021
ISIN
US0345691036
Website
anebulo.com

Frequently asked questions

What was Anebulo Pharmaceuticals, Inc.'s most recent earnings date?

Anebulo Pharmaceuticals, Inc. (ANEB) last reported earnings on May 7, 2026.

Where is Anebulo Pharmaceuticals, Inc. stock listed?

Anebulo Pharmaceuticals, Inc. (ANEB) is listed on Nasdaq.